An open-label, multiple dose, randomized, three-period crossover study in healthy volunteers to evaluate the effect of co-administration of amantadine 100 mg bid and oseltamivir 75 mg bid on the pharmacokinetic properties of amantadine and oseltamivir

Trial Profile

An open-label, multiple dose, randomized, three-period crossover study in healthy volunteers to evaluate the effect of co-administration of amantadine 100 mg bid and oseltamivir 75 mg bid on the pharmacokinetic properties of amantadine and oseltamivir

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Nov 2007

At a glance

  • Drugs Amantadine (Primary) ; Oseltamivir (Primary)
  • Indications Parkinson's disease; Viral infections
  • Focus Pharmacokinetics
  • Sponsors Novartis
  • Most Recent Events

    • 29 Nov 2007 Status change from in progress to completed.
    • 03 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top